Search for: "Sharp v. Merck " Results 161 - 180 of 197
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Dec 2017, 7:09 am
This work will encompass multiple research projects with the current proposals looking at: the role of price differentials, sector specific impacts and enforcement impacts.BREAKING: CJEU holds that SPCs cannot be obtained on the basis of an "end of procedure notice" pursuant to Article 3(b) SPC RegulationMr Justice Arnold referred two questions to the CJEU on the SPC Regulation in Merck Sharp & Dohme v Comptroller-General of Patents [2016]… [read post]
11 Nov 2010, 12:54 pm by Bexis
Merck & Co., 2003 WL 22902622, at *3 n.3 (E.D. [read post]
6 Jan 2017, 2:01 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of… [read post]
23 Dec 2020, 5:31 am by Annsley Merelle Ward
In IPCom v HTC [2020] EWHC 2941 (Pat), IPCom sought to plead a similar point but Birss J took a harder line. [read post]
14 Aug 2023, 5:03 am by CoL .net
(I will have to go away and read Merck Sharp & Dohme Corp v Merck KGaA (2021) 1 SLR 1102 properly.) [read post]
23 Feb 2012, 11:45 am by John J. Sullivan
Merck Sharp & Dohme Corp., ATL-L-9169-11, ALT-L-9166-11; ATL-L-9142-11; ATL-L-9168-11; ATL-L-9157-011, at 3 (N.J. [read post]
14 Aug 2015, 5:00 am
Merck Sharp & Dohme, No. 15-55873, 2015 WL 4645605 (9th Cir. [read post]
3 Aug 2011, 3:31 am by Marie Louise
  General EU – India agreement in WTO dispute raises bar for EU drug seizures (IP Watch) EU: CJEU rules on repackaging of pharma goods: Joined Cases C-400/09 and C-207/10 Orifarm and Paranova v Merck Sharp Dohme (Class 46) (IPKat) EU: Ophtal v Oftal Cusi- General Court upholds finding of no likelihood of confusion for identical goods in T-160/09 (Class 46) EU: The holiday is over: a close reading of the opinion in Medeva: Joined Cases C? [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) Cubicin (Daptomycin) – US: Cubist Pharmaceuticals to oppose Teva’s attempt to add inequitable conduct defense in patent infringement action (SmartBrief) Dorzolamide/Timolol – Netherlands: Preliminary injunction judge rules UK invalidity decision not sufficient to rule non-negligible chance that (Dutch part of) patent will be invalidated in proceedings on the merits: Merck Sharp & Dohme v. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Atripla (Emtricitabine) - US: District Court S D New York: Patent infringement suit filed following a Paragraph IV Certification: Merck, Sharp & Dohme Corp. et al. v. [read post]
28 Jun 2018, 1:42 pm by Amy Howe
McCarthy & Holtus: Whether the Fair Debt Collection Practices Act applies to nonjudicial foreclosure proceedings; and Merck Sharp & Dohme v. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al… [read post]
23 Sep 2022, 9:39 am by Annsley Merelle Ward
selected address issues such as SPC protection for combination products, double patenting, prosecution history estoppel and the influence of declarations made by the patentee in parallel proceedings, the possibility for national courts to request technical opinions from the EPO under Art. 25 EPC, and the disappearance of the cautio iudicatum solvi that was sometimes required from foreign plaintiffs launching (patent) proceedings in Belgium.SPC’s for combination products: still more questions… [read post]